155 related articles for article (PubMed ID: 33480975)
21. Evaluation of the expression level of some coding and non-coding genes in oral squamous cell carcinoma.
Ajorlou M; Bina-Jourshari P; Mirzaei S; Maghsoudloo M; Hashemi M; Mousavi-Niri N; Entezari M
Mol Cell Probes; 2023 Aug; 70():101916. PubMed ID: 37355145
[TBL] [Abstract][Full Text] [Related]
22. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
23. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b.
Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C
Biomed Pharmacother; 2017 Dec; 96():299-304. PubMed ID: 28992472
[TBL] [Abstract][Full Text] [Related]
24. The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells.
Winkle M; Tayari MM; Kok K; Duns G; Grot N; Kazimierska M; Seitz A; de Jong D; Koerts J; Diepstra A; Dzikiewicz-Krawczyk A; Steidl C; Kluiver J; van den Berg A
Hum Mol Genet; 2022 Dec; 31(24):4193-4206. PubMed ID: 35866590
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
26. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
27. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
31. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
[TBL] [Abstract][Full Text] [Related]
32. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
33. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
34. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
35. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
36. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA
Guo Q; Zhang Q; Lu L; Xu Y
Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.
An Q; Zhou L; Xu N
Biomed Pharmacother; 2018 Jul; 103():415-420. PubMed ID: 29674277
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of Rho GTPase-related lncRNAs in breast cancer.
Nicknam A; Khojasteh Pour S; Hashemnejad MA; Hussen BM; Safarzadeh A; Eslami S; Taheri M; Ghafouri-Fard S; Jamali E
Pathol Res Pract; 2023 Apr; 244():154429. PubMed ID: 36996609
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge.
Yang T; Chen WC; Shi PC; Liu MR; Jiang T; Song H; Wang JQ; Fan RZ; Pei DS; Song J
J Exp Clin Cancer Res; 2020 Jul; 39(1):139. PubMed ID: 32690100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
